Advertisement

Topics

"Multiple Myeloma Therapeutics Major Developed Markets 2021 Growth" Drugs and Medication Database

18:20 EST 15th February 2019 | BioPortfolio

Here are the most relevant "Multiple Myeloma Therapeutics Major Developed Markets 2021 Growth" Drugs and Medications that we have found in our database.

More Information about "Multiple Myeloma Therapeutics Major Developed Markets 2021 Growth" on BioPortfolio

We have published hundreds of Multiple Myeloma Therapeutics Major Developed Markets 2021 Growth news stories on BioPortfolio along with dozens of Multiple Myeloma Therapeutics Major Developed Markets 2021 Growth Clinical Trials and PubMed Articles about Multiple Myeloma Therapeutics Major Developed Markets 2021 Growth for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Multiple Myeloma Therapeutics Major Developed Markets 2021 Growth Companies in our database. You can also find out about relevant Multiple Myeloma Therapeutics Major Developed Markets 2021 Growth Drugs and Medications on this site too.

Showing "Multiple Myeloma Therapeutics Major Developed Markets 2021 Growth" Drugs and Medications 1–25 of 65

Probably Relevant

Kynamro [kastle therapeutics, llc]

NA

Possibly Relevant

Olopatadine hydrochloride [somerset therapeutics, llc]

OLOPATADINE Hydrochloride Ophthalmic Solution USP, 0.1%Somerset Therapeutics, LLC

Oxygen [albright welding supply co., inc.]

Oxygen

Revlimid [celgene corporation]

These highlights do not include all the information needed to use REVLIMID safely and effectively. See full prescribing information for REVLIMID. REVLIMID [lenalidomide] capsules, for oral use Initial U.S. Approval: 2005

Melphalan hydrochloride [sagent pharmaceuticals]

Melphalan Hydrochloride for Injection(For Intravenous Infusion)

Oxygen [breathe easy therapeutics, inc]

NA

Melphalan hydrochloride [par pharmaceutical, inc.]

Melphalan Hydrochloride for Injection

Alkeran [apo-pharma usa, inc]

ALKERAN (melphalan hydrochloride) for Injection

Melphalan hydrochloride [generamedix inc.]

NA

Melphalan hydrochloride [dr.reddy's laboratories inc]

Melphalan Hydrochloride For Injection 50 mg

Melphalan hydrochloride [actavis pharma, inc.]

Melphalan Hydrochloride for Injection

Melphalan hydrochloride [mylan institutional llc]

Melphalan Hydrochloride for Injection

Melphalan hydrochloride [mylan institutional llc]

Melphalan Hydrochloride for Injection

Melphalan hydrochloride [mylan institutional llc]

Melphalan Hydrochloride for Injection

Pomalyst [celgene corporation]

These highlights do not include all the information needed to use POMALYST safely and effectively. See full prescribing information for POMALYST. POMALYST (pomalidomide) capsules, for oral useInitial U.S. Approval: 2013

Diclofenac sodium delayed release [cambridge therapeutics technologies, llc]

Diclofenac Sodium

Olopatadine hydrochloride [a-s medication solutions]

OLOPATADINE Hydrochloride Ophthalmic Solution USP, 0.1%Somerset Therapeutics, LLC

Sentradine [physician therapeutics llc]

Sentradine

Empliciti [e.r. squibb & sons, l.l.c.]

These highlights do not include all the information needed to use EMPLICITI safely and effectively. See full prescribing information for EMPLICITI. EMPLICITI (elotuzumab) for injection, for intravenous useInitial U.S. Approval: 2015

Folotyn [allos therapeutics]

These highlights do not include all the information needed to use FOLOTYN safely and effectively. See full prescribing information for FOLOTYN.FOLOTYN (pralatrexate injection), for intravenous use Initial U.S. Approval: 2009

Sodium fluoride [mayne pharma inc]

Sodium Fluoride Drops 0.5 mg Drops Peach Flavored

Urised [key therapeutics]

Urised

Bortezomib [fresenius kabi usa, llc]

These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION.BORTEZOMIB for injection, for intravenous useInitial U.S. Approval: 2003

Tobramycin [somerset therapeutics, llc]

Rx OnlyFor Topical Ophthalmic Use Only

Doxil [janssen products, lp]

These highlights do not include all the information needed to use DOXIL safely and effectively. See full prescribing information for DOXIL. DOXIL (doxorubicin hydrochloride liposome injection), for intravenous useInitial U.S. Approval: 1995



Advertisement
Quick Search
Advertisement
Advertisement